Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Apical Aortic Conduit Infection 27 Years After Repaired Left Ventricular Outflow Tract Obstruction.

Carpenter DJ, Fiore AC, Huddleston CB.

World J Pediatr Congenit Heart Surg. 2014 Jun 23;5(3):478-480. [Epub ahead of print]

PMID:
24958058
2.

Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomnia.

Ratti E, Carpenter DJ, Zamuner S, Fernandes S, Squassante L, Danker-Hopfe H, Archer G, Robertson J, Alexander R, Trist DG, Merlo-Pich E.

Sleep. 2013 Dec 1;36(12):1823-30. doi: 10.5665/sleep.3208.

3.

Injury-related hospital admissions of military dependents compared with similarly aged nonmilitary insured infants, children, and adolescents.

Pressley JC, Dawson P, Carpenter DJ.

J Trauma Acute Care Surg. 2012 Oct;73(4 Suppl 3):S236-42. doi: 10.1097/TA.0b013e31827035f2.

PMID:
23026960
4.

Commentary on: Chi JH. Metallographic analysis and fire dynamics simulation for electrical fire scene reconstruction. J Forensic Sci 2012;57(1):246-9.

Carpenter DJ.

J Forensic Sci. 2012 Sep;57(5):1409; author reply 1410. doi: 10.1111/j.1556-4029.2012.02242.x. No abstract available.

PMID:
22950698
5.

Commentary on: Chi JH, Wu SH, Shu CM. Using fire dynamics simulator to reconstruct a hydroelectric power plant fire accident. J Forensic Sci 2011;56(6):1639-44.

Carpenter DJ.

J Forensic Sci. 2012 Jul;57(4):1144. doi: 10.1111/j.1556-4029.2012.02157.x. No abstract available.

PMID:
22748156
7.

Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.

Carpenter DJ, Fong R, Kraus JE, Davies JT, Moore C, Thase ME.

J Clin Psychiatry. 2011 Nov;72(11):1503-14. doi: 10.4088/JCP.08m04927blu. Epub 2011 Feb 22.

PMID:
21367354
8.

Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy.

Kraus JE, Horrigan JP, Carpenter DJ, Fong R, Barrett PS, Davies JT.

J Affect Disord. 2010 Jan;120(1-3):40-7. doi: 10.1016/j.jad.2009.04.004. Epub .

PMID:
19439363
9.
10.

Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.

Owens MJ, Krulewicz S, Simon JS, Sheehan DV, Thase ME, Carpenter DJ, Plott SJ, Nemeroff CB.

Neuropsychopharmacology. 2008 Dec;33(13):3201-12. doi: 10.1038/npp.2008.47. Epub 2008 Apr 16.

11.

Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.

Emslie GJ, Wagner KD, Kutcher S, Krulewicz S, Fong R, Carpenter DJ, Lipschitz A, Machin A, Wilkinson C.

J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):709-19.

PMID:
16721321
12.

Analysis of electrocardiographic data following use of paroxetine in pediatric depression and obsessive-compulsive disorder.

Krulewicz S, Carpenter DJ, Fong R, Horrigan JP, Lipschitz A, Perera P, Wagner KD.

J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):422-30.

PMID:
16601647
13.

Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine.

Apter A, Lipschitz A, Fong R, Carpenter DJ, Krulewicz S, Davies JT, Wilkinson C, Perera P, Metz A.

J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):77-90. Review.

PMID:
16553530
14.

An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder.

Berard R, Fong R, Carpenter DJ, Thomason C, Wilkinson C.

J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):59-75.

PMID:
16553529
15.

Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder.

Findling RL, Nucci G, Piergies AA, Gomeni R, Bartolic EI, Fong R, Carpenter DJ, Leeder JS, Gaedigk A, Danoff TM.

Neuropsychopharmacology. 2006 Jun;31(6):1274-85.

16.

Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice.

Michaud EJ, Culiat CT, Klebig ML, Barker PE, Cain KT, Carpenter DJ, Easter LL, Foster CM, Gardner AW, Guo ZY, Houser KJ, Hughes LA, Kerley MK, Liu Z, Olszewski RE, Pinn I, Shaw GD, Shinpock SG, Wymore AM, Rinchik EM, Johnson DK.

BMC Genomics. 2005 Nov 21;6:164.

17.

A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.

Wagner KD, Berard R, Stein MB, Wetherhold E, Carpenter DJ, Perera P, Gee M, Davy K, Machin A.

Arch Gen Psychiatry. 2004 Nov;61(11):1153-62.

PMID:
15520363
18.

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.

Geller DA, Wagner KD, Emslie G, Murphy T, Carpenter DJ, Wetherhold E, Perera P, Machin A, Gardiner C.

J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1387-96.

PMID:
15502598
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk